BACKGROUND: In the failing human heart, abnormalities of Ca(2+) cycling have been described, but there is scant knowledge about Ca(2+) handling in the skeletal muscle of humans with heart failure (HF). We tested the hypothesis that in humans with HF, Ca(2+) cycling proteins in skeletal muscle are abnormal. METHODS AND RESULTS: Ten advanced HF patients (50.4 ± 3.7 years), and 9 age-matched controls underwent vastus lateralis biopsy. Western blot analysis showed that sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA)2a, which is responsible for Ca(2+) sequestration into the sarcoplasmic reticulum(SR), was lower in HF versus controls (4.8 ± 0.5 vs 7.5 ± 0.8 AU, P = .01). Although phospholamban (PLN), which inhibits SERCA2a, was not different in HF versus controls, phosphorylation (SER16 site) of PLN, which relieves this inhibition, was reduced (0.8 ± 0.1 vs 3.9 ± 0.9 AU, P = .004). Dihydropyridine receptors were reduced in HF, (2.1 ± 0.4 vs 3.6 ± 0.5 AU, P = .04). We tested the hypothesis that these abnormalities of Ca(2+) handling protein content and regulation were due to increased oxidative stress, but oxygen radical scavenger proteins were not elevated in the skeletal muscle of HF patients. CONCLUSION: In chronic HF, marked abnormalities of Ca(2+) handling proteins are present in skeletal muscle, which mirror those in failing heart tissue. This suggests a common mechanism, such as chronic augmentation of sympathetic activity and autophosphorylation of Ca(2+)-calmodulin-dependent-protein kinase II.
BACKGROUND: In the failing human heart, abnormalities of Ca(2+) cycling have been described, but there is scant knowledge about Ca(2+) handling in the skeletal muscle of humans with heart failure (HF). We tested the hypothesis that in humans with HF, Ca(2+) cycling proteins in skeletal muscle are abnormal. METHODS AND RESULTS: Ten advanced HF patients (50.4 ± 3.7 years), and 9 age-matched controls underwent vastus lateralis biopsy. Western blot analysis showed that sarco(endo)plasmic reticulum Ca(2+)-ATPase (SERCA)2a, which is responsible for Ca(2+) sequestration into the sarcoplasmic reticulum(SR), was lower in HF versus controls (4.8 ± 0.5 vs 7.5 ± 0.8 AU, P = .01). Although phospholamban (PLN), which inhibits SERCA2a, was not different in HF versus controls, phosphorylation (SER16 site) of PLN, which relieves this inhibition, was reduced (0.8 ± 0.1 vs 3.9 ± 0.9 AU, P = .004). Dihydropyridine receptors were reduced in HF, (2.1 ± 0.4 vs 3.6 ± 0.5 AU, P = .04). We tested the hypothesis that these abnormalities of Ca(2+) handling protein content and regulation were due to increased oxidative stress, but oxygen radical scavenger proteins were not elevated in the skeletal muscle of HF patients. CONCLUSION: In chronic HF, marked abnormalities of Ca(2+) handling proteins are present in skeletal muscle, which mirror those in failing heart tissue. This suggests a common mechanism, such as chronic augmentation of sympathetic activity and autophosphorylation of Ca(2+)-calmodulin-dependent-protein kinase II.
Authors: Kanu R Shah; Pallab K Ganguly; Thomas Netticadan; Amarjit S Arneja; Naranjan S Dhalla Journal: Can J Physiol Pharmacol Date: 2004-07 Impact factor: 2.273
Authors: Andrew R Coggan; Joshua L Leibowitz; Catherine Anderson Spearie; Ana Kadkhodayan; Deepak P Thomas; Sujata Ramamurthy; Kiran Mahmood; Soo Park; Suzanne Waller; Marsha Farmer; Linda R Peterson Journal: Circ Heart Fail Date: 2015-07-15 Impact factor: 8.790
Authors: Carlos E Negrao; Holly R Middlekauff; Igor L Gomes-Santos; Ligia M Antunes-Correa Journal: Am J Physiol Heart Circ Physiol Date: 2015-02-13 Impact factor: 4.733
Authors: Leonardo Nogueira; Amy A Shiah; Paulo G Gandra; Michael C Hogan Journal: Am J Physiol Regul Integr Comp Physiol Date: 2013-05-15 Impact factor: 3.619
Authors: Ligia M Antunes-Correa; Thais S Nobre; Raphaela V Groehs; Maria Janieire N N Alves; Tiago Fernandes; Gisele K Couto; Maria Urbana P B Rondon; Patricia Oliveira; Marta Lima; Wilson Mathias; Patricia C Brum; Charles Mady; Dirceu R Almeida; Luciana V Rossoni; Edilamar M Oliveira; Holly R Middlekauff; Carlos E Negrao Journal: Am J Physiol Heart Circ Physiol Date: 2014-10-10 Impact factor: 4.733
Authors: Holly R Middlekauff; M Anthony Verity; Tamara B Horwich; Gregg C Fonarow; Michele A Hamilton; Perry Shieh Journal: Clin Res Cardiol Date: 2013-04-11 Impact factor: 5.460
Authors: Vinaya Mulkareddy; Susan B Racette; Andrew R Coggan; Linda R Peterson Journal: Biochim Biophys Acta Mol Basis Dis Date: 2018-09-24 Impact factor: 5.187
Authors: Marino DiFranco; Marbella Quiñonez; Perry Shieh; Gregg C Fonarow; Daniel Cruz; Mario C Deng; Julio L Vergara; Holly R Middlekauff Journal: PLoS One Date: 2014-10-13 Impact factor: 3.240
Authors: Aline V Bacurau; Telma F Cunha; Rodrigo W Souza; Vanessa A Voltarelli; Daniele Gabriel-Costa; Patricia C Brum Journal: Oxid Med Cell Longev Date: 2016-01-19 Impact factor: 6.543